Nalgesin S (Naproxen Sodium)

Naproxen sodium blocks the activity of cyclooxygenase‑1 and cyclooxygenase‑2 enzymes, which are required for the synthesis of prostaglandins. By lowering prostaglandin levels, it diminishes inflammation, pain signaling, and fever responses.

The appropriate dose of Nalgesin S is determined by the prescribing healthcare professional based on the individual’s condition, age, renal and hepatic function, and other medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for naproxen sodium during pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and only under medical supervision. Breastfeeding mothers should consult their physician before use.

To order Nalgesin S, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Both naproxen sodium (Nalgesin S) and ibuprofen belong to the NSAID class and share similar mechanisms. Naproxen generally has a longer half‑life, allowing twice‑daily dosing, whereas ibuprofen often requires three‑four times daily. Individual response, safety profile, and physician preference guide the choice.

Store Nalgesin S at room temperature, below 25 °C. Keep the tablets in the original container, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Nalgesin S is taken orally with a full glass of water. It may be taken with or without food, although taking it with food can reduce gastrointestinal discomfort. Swallow the tablet whole; do not crush or chew unless instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulceration, cardiovascular events such as heart attack or stroke, and renal impairment that may manifest as reduced urine output or swelling. Patients should seek immediate medical attention if they notice black stools, chest pain, sudden shortness of breath, or severe swelling.

Nalgesin S should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulcers, severe heart failure, uncontrolled hypertension, or significant renal or hepatic impairment. It is also contraindicated in patients taking certain anticoagulants without medical supervision.